286 related articles for article (PubMed ID: 17425380)
21. p63 expression in benign and malignant breast lesions.
Stefanou D; Batistatou A; Nonni A; Arkoumani E; Agnantis NJ
Histol Histopathol; 2004 Apr; 19(2):465-71. PubMed ID: 15024707
[TBL] [Abstract][Full Text] [Related]
22. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
[TBL] [Abstract][Full Text] [Related]
23. [Adenocarcinomas of nasal cavities and paranasal sinuses: Diagnostic pitfalls in sinonasal glandular lesions].
Poizat F; Gonzalez AM; Raynaud P; Baldet P; Garrel R; Crampette L; Costes V
Ann Pathol; 2009 Sep; 29(4):286-95. PubMed ID: 19900634
[TBL] [Abstract][Full Text] [Related]
24. Respiratory epithelial adenomatoid hamartoma: diagnostic pitfalls with emphasis on differential diagnosis.
Sangoi AR; Berry G
Adv Anat Pathol; 2007 Jan; 14(1):11-6. PubMed ID: 17198306
[TBL] [Abstract][Full Text] [Related]
25. Respiratory epithelial adenomatoid hamartomas of the sinonasal tract.
Mortuaire G; Pasquesoone X; Leroy X; Chevalier D
Eur Arch Otorhinolaryngol; 2007 Apr; 264(4):451-3. PubMed ID: 17089137
[TBL] [Abstract][Full Text] [Related]
26. Composite intestinal-type adenocarcinoma and small cell carcinoma of sinonasal tract.
Jain R; Gramigna V; Sanchez-Marull R; Perez-Ordoñez B
J Clin Pathol; 2009 Jul; 62(7):634-7. PubMed ID: 19321468
[TBL] [Abstract][Full Text] [Related]
27. [Sinonasal adenocarcinomas reviewed. Prognostic value of WHO 2005 histological classification].
El Ayoubi A; Poizat F; Garrel R; Costes V; Guerrier B; Essakalli L; Kzadri M; Crampette L
Ann Otolaryngol Chir Cervicofac; 2009 Sep; 126(4):175-81. PubMed ID: 19591973
[TBL] [Abstract][Full Text] [Related]
28. Respiratory epithelial adenomatoid hamartoma: a review.
Fitzhugh VA; Mirani N
Head Neck Pathol; 2008 Sep; 2(3):203-8. PubMed ID: 20614315
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotypic characterization of anal gland carcinoma: loss of p63 and cytokeratin 5/6.
Lisovsky M; Patel K; Cymes K; Chase D; Bhuiya T; Morgenstern N
Arch Pathol Lab Med; 2007 Aug; 131(8):1304-11. PubMed ID: 17683193
[TBL] [Abstract][Full Text] [Related]
30. Distribution of basal/myoepithelial markers in benign and malignant bronchioloalveolar proliferations of the lung.
Saad RS; Liu YL; Silverman JF
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):219-25. PubMed ID: 20065853
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
[TBL] [Abstract][Full Text] [Related]
32. Necrotizing sialometaplasia versus invasive carcinoma of the head and neck: the use of myoepithelial markers and keratin subtypes as an adjunct to diagnosis.
Rizkalla H; Toner M
Histopathology; 2007 Aug; 51(2):184-9. PubMed ID: 17650214
[TBL] [Abstract][Full Text] [Related]
33. Histomorphological and immunophenotypical spectrum of cutaneous myoepitheliomas: A series of 35 cases.
Plaza JA; Brenn T; Chung C; Salim S; Linos KD; Jour G; Duran Rincon J; Wick M; Sangueza M; Gru AA
J Cutan Pathol; 2021 Jul; 48(7):847-855. PubMed ID: 33340147
[TBL] [Abstract][Full Text] [Related]
34. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.
Zhou M; Shah R; Shen R; Rubin MA
Am J Surg Pathol; 2003 Mar; 27(3):365-71. PubMed ID: 12604893
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical staining of papillary breast lesions.
Troxell ML; Masek M; Sibley RK
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):145-53. PubMed ID: 17525625
[TBL] [Abstract][Full Text] [Related]
36. Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel.
Raspollini MR; Baroni G; Taddei A; Taddei GL
Arch Pathol Lab Med; 2003 Dec; 127(12):1586-90. PubMed ID: 14632574
[TBL] [Abstract][Full Text] [Related]
37. A Subset of Sinonasal Non-Intestinal Type Adenocarcinomas are Truly Seromucinous Adenocarcinomas: A Morphologic and Immunophenotypic Assessment and Description of a Novel Pitfall.
Purgina B; Bastaki JM; Duvvuri U; Seethala RR
Head Neck Pathol; 2015 Dec; 9(4):436-46. PubMed ID: 25690258
[TBL] [Abstract][Full Text] [Related]
38. Update on inverted epithelial lesions of the sinonasal and nasopharyngeal regions.
Sarioglu S
Head Neck Pathol; 2007 Sep; 1(1):44-9. PubMed ID: 20614281
[No Abstract] [Full Text] [Related]
39. Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes.
Choi HR; Sturgis EM; Rashid A; DeMonte F; Luna MA; Batsakis JG; El-Naggar AK
Hum Pathol; 2003 Nov; 34(11):1101-7. PubMed ID: 14652810
[TBL] [Abstract][Full Text] [Related]
40. Ameloblastoma, calcifying epithelial odontogenic tumor, and glandular odontogenic cyst show a distinctive immunophenotype with some myoepithelial antigen expression.
Gratzinger D; Salama ME; Poh CF; Rouse RV
J Oral Pathol Med; 2008 Mar; 37(3):177-84. PubMed ID: 18251942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
